Company	Share, %
Eliem Therapeutics, Inc.	47.44
Vor Biopharma Inc.	33.37
Aerovate Therapeutics, Inc.	29.66
SAB Biotherapeutics, Inc.	25.73
PepGen Inc.	25.13
Acrivon Therapeutics, Inc.	21.25
AN2 Therapeutics, Inc.	18.65
Janux Therapeutics, Inc.	17.74
Wave Life Sciences Ltd.	17.37
DICE Therapeutics, Inc.	16.46
Nkarta, Inc.	15.79
Werewolf Therapeutics, Inc.	14.38
iTeos Therapeutics, Inc.	12.35
Verona Pharma plc	12.19
Icosavax, Inc.	11.91
GH Research PLC	10.74
Unicycive Therapeutics, Inc.	9.99
BELLUS Health Inc.	9.97
Taysha Gene Therapies, Inc.	9.88
Solid Biosciences Inc.	9.07
Harpoon Therapeutics, Inc.	8.86
RxSight, Inc.	8.5
Geron Corporation	8.45
Alpine Immune Sciences, Inc.	7.49
Vaxcyte, Inc.	7.28
Black Diamond Therapeutics, Inc.	6.82
MacroGenics, Inc.	6.49
Mineralys Therapeutics, Inc.	6.4
CymaBay Therapeutics, Inc.	6.05
Connect Biopharma Holdings Limited	5.56
Cytek Biosciences, Inc.	5.21
Enliven Therapeutics, Inc.	5.16
ImmunoGen	5
UroGen Pharma Ltd.	4.81
NanoString Technologies, Inc.	3.58
Legend Biotech Corporation	3.44
Apogee Therapeutics, Inc. Common Stock	3.38
ARS Pharmaceuticals, Inc.	3.18
IGM Biosciences, Inc.	2.82
Axsome Therapeutics, Inc.	2.11
COMPASS Pathways plc	2.08
CureVac N.V.	1.23
Tourmaline Bio, Inc.	0.94